Arkolith/Insider Trading/KLRS/Form 4

Feinsod Matthew

Chief Medical OfficerKalaris Therapeutics, Inc. (KLRS) · full profile →Form 4 · filed Apr 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 10, 2025Grant(A)71K—$071K
Apr 10, 2025Grant(A)101K—$0101K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-053338) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML